Roundup transformed farming in the U.S. Could it change regulation too?

The Supreme Court will soon rule on who gets to decide when a product needs a cancer warning – and who can sue if they’ve been exposed. At the center of the highly politicized debate is America’s most successful weedkiller, Roundup.

Carey Gillam, editor-in-chief of The New Lede and contributor at The Guardian.

Ben Felder, editor-in-chief, Investigate Midwest.

Bill Billings, Iowa resident and cancer survivor.

Melissa Perry, epidemiologist and dean of the College of Public Health at George Mason University.

Dennis Weisenburger, professor emeritus of hematopathology at University of Nebraska Medical Center’s Department of Pathology, Microbiology and Immunology.

The version of our broadcast available at the top of this page and via podcast apps is a condensed version of the full show. You can listen to the full, unedited broadcast here:

The first draft of this transcript was created by Descript, an AI transcription tool. An On Point producer then thoroughly reviewed, corrected, and reformatted the transcript before publication. The use of this AI tool creates the capacity to provide these transcripts.